Trial Profile
A Retrospective study comparing the efficacy and safety of Brincidofovir and Cidofovir in controlling HCT-related adenoviremia in Pediatric patients
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 08 Feb 2017
Price :
$35
*
At a glance
- Drugs Brincidofovir (Primary) ; Cidofovir
- Indications Adenovirus infections
- Focus Adverse reactions; Therapeutic Use
- 08 Feb 2017 New trial record
- 02 Feb 2017 Results published in the Blood